Wu competitive analysis

Explore patent oppositions filed by Wu against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026
Patent NumberTitleApplicantOpposition Date
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025
Solid Oral Formulation Of FenretinideLAURENT PHARMACEUTICALSSep 9, 2025
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XCHUGAI SEIYAKU KABUSHIKI KAISHAAug 25, 2025
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
Expansion AnchorFISCHERWERKEJul 8, 2025
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 5, 2025
System And Method For Providing Imaging ParametersDRR DENTALApr 25, 2025
Food Preparation Device For Cutting Food, Crushing Attachment And MethodVORWERK & INTERHOLDINGApr 4, 2025
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025

Explore Wu's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 29, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 12, 2025Knitting Needle1
Apr 17, 2024Food Processor Arrangement And Chopping Assembly For A Food Processor1
Mar 27, 2024Phase-Change Electric Water Heater And Water Temperature Control Method1
Nov 1, 2023Power Generation Device1
Jan 12, 2022Reduction Of Blockages In A Cryogenic Refrigerator System Such As For Magnetic Resonance Imaging Systems1
Mar 3, 2021Electronic Ink Display Screen And Manufacturing Method1

Latest PTAB cases involving Wu

Discover the latest PTAB cases involving Wu, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 3, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Wu

IPR2023-00684Mar 31, 2023WUHAN HEALTHGEN BIOTECHNOLOGYVENTRIA BIOSCIENCEInstitution Denied
IPR2022-00712Mar 17, 2022WUHAN HEALTHGEN BIOTECHNOLOGY OF WUHANVENTRIA BIOSCIENCEInstitution Denied
IPR2022-00407Jan 7, 2022WUHAN HEALTHGEN BIOTECHNOLOGY OF WUHANVENTRIA BIOSCIENCETerminated-Settled

Peer Comparison New

IP litigation analysis comparing Wu with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB33 - - -
CITY OF HOPE - 4 - -
NOVARTIS6424 - 21
REGENERON PHARMACEUTICALS3894931